<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>177(5)</volume><submitter>Curto M</submitter><pubmed_abstract>The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin, is a membrane/cytoskeleton-associated protein that mediates contact-dependent inhibition of proliferation. Here we show that upon cell-cell contact Merlin coordinates the processes of adherens junction stabilization and negative regulation of epidermal growth factor receptor (EGFR) signaling by restraining the EGFR into a membrane compartment from which it can neither signal nor be internalized. In confluent Nf2(-/-) cells, EGFR activation persists, driving continued proliferation that is halted by specific EGFR inhibitors. These studies define a new mechanism of tumor suppression, provide mechanistic insight into the poorly understood phenomenon of contact-dependent inhibition of proliferation, and suggest a therapeutic strategy for NF2-mutant tumors.</pubmed_abstract><journal>The Journal of cell biology</journal><pagination>893-903</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2064288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.</pubmed_title><pmcid>PMC2064288</pmcid><pubmed_authors>Liu CH</pubmed_authors><pubmed_authors>Lallemand D</pubmed_authors><pubmed_authors>Curto M</pubmed_authors><pubmed_authors>McClatchey AI</pubmed_authors><pubmed_authors>Cole BK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.</name><description>The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin, is a membrane/cytoskeleton-associated protein that mediates contact-dependent inhibition of proliferation. Here we show that upon cell-cell contact Merlin coordinates the processes of adherens junction stabilization and negative regulation of epidermal growth factor receptor (EGFR) signaling by restraining the EGFR into a membrane compartment from which it can neither signal nor be internalized. In confluent Nf2(-/-) cells, EGFR activation persists, driving continued proliferation that is halted by specific EGFR inhibitors. These studies define a new mechanism of tumor suppression, provide mechanistic insight into the poorly understood phenomenon of contact-dependent inhibition of proliferation, and suggest a therapeutic strategy for NF2-mutant tumors.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Jun</publication><modification>2024-11-12T21:35:38.307Z</modification><creation>2019-03-26T23:02:24Z</creation></dates><accession>S-EPMC2064288</accession><cross_references><pubmed>17548515</pubmed><doi>10.1083/jcb.200703010</doi></cross_references></HashMap>